• linkedin
  • Increase Font
  • Sharebar

    JDD honors Adam Friedman, M.D., for educational contributors

    Dr. FriedmanAdam Friedman, M.D., was honored with the Innovations in Residency Training Award by the Journal of Drugs in Dermatology (JDD) at the Orlando Dermatology Aesthetic & Clinical Conference (ODAC) held in January. The award recognizes individuals who serve as exemplary role models for dermatology residents and innovate improvements in residency programs.

    “Dr. Adam Friedman embodies the spirit of the award and more,” says Shelley Tanner, CEO and president of SanovaWorks, parent company of the JDD and ODAC. “He looks towards the future of dermatology and those who will carry it forward.”

    Dr. Friedman is the residency program director and director of translational research at the George Washington University School of Medicine. He is also deputy chair of the American Academy of Dermatology’s Poster Task Force, senior editor of the Dermatology In-Review online workshop and cram pack, and director of the Oakstone Institute Dermatology Board Review.

    The award recognizes Dr. Friedman for the educational program he developed at the GWU School of Medicine, Krazy Kodachromes. It is a three-hour, image-based review series available in person and online at http://www.jddonline.com/krazy-kodachromes.

    “As medical director for ODAC, Dr. Friedman is instrumental in cultivating the educational program that is enjoyed by many residents across the nation each year,” says Shelley Tanner, CEO and president of SanovaWorks, parent company of the JDD and ODAC.

    The Innovations in Residency Training Award given by the JDD is nominated and chosen through the recommendation of a panel of senior national thought-leaders in dermatology, a committee of dermatology residents and several industry leaders.

    Sarah Thuerk
    Sarah Thuerk is associate editor of Healthcare Traveler magazine.

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Latest Tweets Follow